Figure 1: Antibody levels in the 200 study participants about three to four weeks after overcoming the disease (the participant numbers are given by antibody level groups on top of the columns)
Figure 1: Antibody levels in the 200 study participants about three to four weeks after overcoming the disease (the participant numbers are given by antibody level groups on top of the columns)